* Newstin.com is for sale! * After achieving our strategic milestone, we are offering for sale: Newstin.com and all 14 related domains featuring 1 million unique visitors per month + continuously updated news database of 37 million articles in 12 world languages from 166,000 global and weighted sources + 2.1 billion metadata * To seize this unique chance, contact invest@newstin.com. * Newstin.com is for sale! *

Monoclonal Antibody Hb3: A Marker For Colon Cancer Progression Or As A Therapeutic Target?
medicalnewstoday.com
May 4, 2008 3 related
        

There are a number of researchers who are searching for useful tumor markers to indicate cure. Antigens are being applied as an effective target in clinical therapy. Hb3 is an anti-colorectal cancer monoclonal antibody produced in the researchers' laboratory, and whose sensitivity and specificity... [read full story]                    

Add Comment
There are also 3 related articles
View all news articles about*:
Ambulatory Body Cancer Cancers Care China Colon Gastroenterology Health Location Medical Pharmaceuticals Research
*Newstin tag cloud displays all featured persons, associated organizations, related topics, regions and companies

View other selected articles:

ImmunoCellular Therapeutics Announces Filing Of Patent Application For A Novel Cancer Stem Cell...

medicalnewstoday.com
2 mins ago 4 related
        

ImmunoCellular Therapeutics, Ltd. (OTC: IMUC) (IMUC), a biotechnology company, announced the filing of a provisional U.S. patent application relating to its novel vaccine technology targeting cancer stem cells. The vaccine...

add comment
                   

Cyclacel Announces Completion Of Enrollment In Phase 2 Trial Of Sapacitabine In Elderly AML

medicalnewstoday.com
2 mins ago
        

lCyclacel Pharmaceuticals, Inc. (NASDAQ:CYCC) (NASDAQ:CYCCP) announced today the completion of enrollment as per protocol in the Phase 2 clinical trial of sapacitabine, the Company's oral nucleoside analogue, in elderly...

add comment
                   

Greenspan's legacy questioned amid crisis

signonsandiego.com
6 mins ago 2 related
        

George Soros, the prominent financier, avoids using the financial contracts known as derivatives “because we don't really understand how they work.” Felix Rohatyn, the investment banker who saved New York from financial...

add comment
                   

Don't Panic

forbes.com
12 mins ago
        

Washington, D.C. - The Dow has been avalanching downward, and the July to September summary of 401(k) statements in people's mailboxes look like black diamond ski slopes. "I would worry about a crash on Monday, but it could...

add comment